<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04576286</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R32/2020</org_study_id>
    <nct_id>NCT04576286</nct_id>
  </id_info>
  <brief_title>Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder</brief_title>
  <official_title>Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      En bloc resection of bladder tumors (ERBT) may improve staging quality and perioperative&#xD;
      morbidity and influence tumour recurrence&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Modern laser technology has led to new alternatives to conventional TURBT (cTURBT). The&#xD;
      advocates of ERBT have three goals: to improve resection quality, lower perioperative&#xD;
      complication rates, and decrease recurrence rates at resection sites. The present study is&#xD;
      the first to compare the results of laser and electric en bloc resection of bladder cancer&#xD;
      with respect to the aforementioned goals.&#xD;
&#xD;
      we aimTo compare the clinical outcome in the form of safety and efficacy between Holmium and&#xD;
      bipolar transurethral en bloc resection of urinary bladder tumors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patients will be blinded to the type of intervention as well as the data collector and the statistician.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>number of participant with Conversion to the TURBT</measure>
    <time_frame>intraoperative finding</time_frame>
    <description>conversion from the enbloc way of resection to the standard trans-urethral resection of bladder tumors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>intraoperative finding</time_frame>
    <description>calculation of operative time in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of detrusor muscle in resected sample</measure>
    <time_frame>one day after surgery during pathological evaluation</time_frame>
    <description>presence of muscle layer in the pathological specimen (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resected specimen's edge</measure>
    <time_frame>one day after surgery during pathological evaluation</time_frame>
    <description>tumor free margin (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative complication: bladder perforation</measure>
    <time_frame>intraoperative</time_frame>
    <description>(Yes/No) bladder perforation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of obturator reflex</measure>
    <time_frame>intraoperative</time_frame>
    <description>(Yes/No) energy induced obturator reflex</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hematuria</measure>
    <time_frame>postoperative complication up to 2 weeks</time_frame>
    <description>(Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative catheterization time in hours</measure>
    <time_frame>postoperative complication up to 2 weeks</time_frame>
    <description>time till catheter removal in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative irrigation time in hours</measure>
    <time_frame>postoperative in hours maximum 1 day</time_frame>
    <description>hours for the need of postoperative irrigation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate of tumors according to time interval</measure>
    <time_frame>1 year</time_frame>
    <description>recurrence of tumor in the follow up cystoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate of tumors according to tumor location</measure>
    <time_frame>1 year</time_frame>
    <description>recurrence of tumor in the follow up cystoscopy in the same site or in different site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Urinary Bladder Neoplasm</condition>
  <arm_group>
    <arm_group_label>Holmium en bloc resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bipolar en bloc resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bipolar en bloc tumor resection of urinary bladder tumors</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Holmium versus Bipolar en bloc transurethral resection</intervention_name>
    <description>After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician.&#xD;
Intervention: all procedures will be done by an expert surgeon who performed over 50 cases of en bloc urinary bladder tumor resection with each energy source. In group A, Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency for Group A and bipolar en bloc resection for Group B. A 550 nm flexible laser fiber will be used in group A and a bipolar resection loop for group B.</description>
    <arm_group_label>Holmium en bloc resection</arm_group_label>
    <arm_group_label>bipolar en bloc resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients of both sexes presented with urinary bladder tumor aiming for complete&#xD;
             resection as diagnosed by Ultrasound with or without CT prior histopathological&#xD;
             assessment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with signs of extravesical tumor extension where complete resection will not&#xD;
             beneficial or unable to proceed to complete resection due to huge tumor burden either&#xD;
             huge single tumor more than 5 cm or multiple tumors that are not candidate for&#xD;
             complete resection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams University Hospitals</name>
      <address>
        <city>Cairo</city>
        <zip>11361</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AHMED M HIGAZY</last_name>
      <phone>01002609801</phone>
      <email>ahmedmaherhigazy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Maher Gamil Ahmed Higazy</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>urinary bladder tumors</keyword>
  <keyword>en bloc resection</keyword>
  <keyword>holmium laser</keyword>
  <keyword>bipolar</keyword>
  <keyword>TURBT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT04576286/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

